Page last updated: 2024-12-07

carazostatin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

carazostatin: structure given in first source; MF C20-H25-N-O: free radical scavenger; isolated from Streptomyces chromofuscus DC 118 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID130857
CHEMBL ID3309625
SCHEMBL ID13424608
MeSH IDM0174353

Synonyms (13)

Synonym
1-heptyl-2-methyl-9h-carbazol-3-ol
dc 118
9h-carbazol-3-ol, 1-heptyl-2-methyl-
carbazostatin
carazostatin
SMP2_000073
1-heptyl-3-hydroxy-2-methylcarbazole
126168-32-9
CHEMBL3309625
SCHEMBL13424608
DTXSID50155094
J-005342
AKOS040745648
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1179806Antioxidant activity assessed as reduction of Cu2+ to Cu+ after 3 mins by PAO-SO method2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Antioxidant effects of the highly-substituted carbazole alkaloids and their related carbazoles.
AID1179804Antioxidant activity assessed as DPPH radical scavenging capacity after 30 mins by UV spectrophotometry2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Antioxidant effects of the highly-substituted carbazole alkaloids and their related carbazoles.
AID1179807Cytotoxicity against human HCT116 cells assessed as reduction cell viability at 100 uM after 48 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Antioxidant effects of the highly-substituted carbazole alkaloids and their related carbazoles.
AID1179805Antioxidant activity assessed as ABTS+ radical scavenging capacity after 16 hrs by UV spectrophotometry2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Antioxidant effects of the highly-substituted carbazole alkaloids and their related carbazoles.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.01 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]